Skip to main content

Table 3 Patient characteristics at the EUROASPIRE IV study visit by chronic kidney diseasea

From: Patient’s and physician’s awareness of kidney disease in coronary heart disease patients – a cross-sectional analysis of the German subset of the EUROASPIRE IV survey

 

normal kidney function n = 345 (65.1%)

chronic kidney disease n = 185 (34.9%)

p-value

Age, yrs

65.4 (59.6; 72.2)

73.4 (66.5; 77.0)

<0.001

Male gender

291 (84.4%)

145 (78.4%)

0.09

Total year in education, yrs

12 (11; 15)

11 (11; 14)

<0.001

Education level (higher vs. lower levelsb)

72 (20.9%)

27 (14.6%)

0.08

History of CHD

 Duration of CHD

2.7 (1.9; 6.4)

3.4 (2.0; 12.9)

<0.01

 CHD history

  - CABG

77 (22.3%)

59 (31.9%)

0.02

  - PCI/stent

278 (78.6%)

138 (74.6%)

0.12

  - AMI

131 (38.0%)

49 (42.7%)

0.30

 History of heart failure

40 (11.6%)

38 (20.7%)

<0.01

 History of stroke

33 (9.8%)

22 (11.9%)

0.45

 History of peripheral artery disease

18 (5.2%)

29 (15.7%)

<0.001

Classic CV risk factors

 BMI [kg/m2]

28.0 (25.9; 30.7)

29.5 (27.0; 32.8)

<0.001

 Overweight (BMI ≥25)

281 (82.2%)

168 (91.3%)

<0.01

 Obesity (BMI ≥30)

105 (30.7%)

86 (46.7%)

<0.001

 Blood pressure

  Systolic

133 (122; 148)

138 (128; 152)

<0.01

  Diastolic

80 (73; 87)

81 (73; 88)

0.67

 Hypertensionc

142 (41.2%)

96 (52.2%)

0.02

 LDL-cholesterol (mmol/l)

2.59 (2.16; 3.14)

2.43 (1.98; 2.98)

0.02

 Hyperlipidemia

  LDL cholesterol ≥2.5 mmol/l

188 (56.1%)

77 (45.6%)

0.03

  LDL cholesterol ≥1.8 mmol/l

307 (91.6%)

143 (84.6%)

0.02

 Diabetesd

70 (20.5%)

75 (41.4%)

<0.001

 Smokinge

49 (14.2%)

14 (7.6%)

0.02

Chronic kidney disease

 SCrstudy-visit (mg/dl)

1.0 (0.8; 1.0)

1.2 (1.1; 1.4)

<0.001

 eGFRCKD-EPI (ml/min/1.73m2)

81.0 (71.2; 90.4)

53.9 (46.6; 62.6)

<0.001

 ACRstudy-visit (mg/g)

2.9 (0; 7.4)

20.4 (5.0; 78.5)

<0.001

 Information on impaired kidney function in a discharge letter of a hospital stay due to CHDf

6 (1.9%)

31 (19.0%)

<0.001

  1. Data are n(%), median (inter quartile range), analyses restricted to patients without missing values in respective variables
  2. Abbreviations: CHD coronary heart disease, CABG coronary artery bypass grafting, PCI percutaneous coronary intervention, AMI acute myocardial infarction, BMI body mass index, LDL low density lipoprotein, SCr serum creatinine, eGFR estimated glomerular filtration rate, ACR urinary albumin/creatinine ratio
  3. aCKD (stages CKD-G3 and higher, G2A2, G2A3, G1A3) vs. normal kidney function (G1A1, G1A2, G2A1)
  4. bHigher (intermediate between secondary level and university [e.g. technical training], College/University completed, post graduate degree) vs. lower levels of education
  5. cAs recommended by the German Society of Cardiology as blood pressure ≥ 140/90 mmHg, ≥140/80 mmHg in patients with diabetes, ≥140/85 mmHg in diabetes, ≥150/90 mmHg in patients >80 years, ≥130/90 mmHg in patients with CKD
  6. dSelf-reported diabetes or impaired fasting glucose/impaired glucose tolerance
  7. eSelf-reported or CO >10 ppm
  8. fEUROASPIRE IV index hospital stay